Journal of Pharmaceutical Technology
Kapak Resmi
Makale Gönder Hakemlik İsteği Gönder Amaç ve Kapsam Yazım Kuralları Etik İlkeler ve Yayın Politikası Son Sayı Arşiv Editör Kurulu İletişim
...
Giriş
e-ISSN 2717-7904 | Yayın Aralığı Yılda 3 Sayı | Başlangıç: 2020 | Yayıncı Mustafa Sinan KAYNAK | www.jpharm.tech


Journal Info


Journal of Pharmaceutical Technology “JPharmTech” is an online peer-reviewed journal following the guidelines provided by the International Committee of Medical Journal Editors (ICMJE) and Committee on Publication Ethics (COPE). All published articles in the JPharmTech will be assigned with a unique Digital Objective Identifier (DOI) provided by CrossRef and archived by the LOCKSS system, which guarantees long-term digital preservation of the paper.


JPharmTech is an open-access journal. It provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. The manuscripts submitted to the JPharmTech are double-blind peer-reviewed, and the review process is completed in approximately 30 days. According to the reviewers’ comments, the submitted papers are accepted or rejected. Submitted manuscripts must not have been previously published elsewhere and not currently be under review by another journal.


Processing and publication are free of charge. JPharmTech publishes three issues per year (April, August, and December) and accepts research articles and review articles on all aspects of pharmaceutical technology. Corresponding authors should submit their manuscripts through the online submission system of Dergipark. 

Journal of Pharmaceutical Technology

e-ISSN 2717-7904 | Yayın Aralığı Yılda 3 Sayı | Başlangıç: 2020 | Yayıncı Mustafa Sinan KAYNAK | www.jpharm.tech
Kapak Resmi


Journal Info


Journal of Pharmaceutical Technology “JPharmTech” is an online peer-reviewed journal following the guidelines provided by the International Committee of Medical Journal Editors (ICMJE) and Committee on Publication Ethics (COPE). All published articles in the JPharmTech will be assigned with a unique Digital Objective Identifier (DOI) provided by CrossRef and archived by the LOCKSS system, which guarantees long-term digital preservation of the paper.


JPharmTech is an open-access journal. It provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. The manuscripts submitted to the JPharmTech are double-blind peer-reviewed, and the review process is completed in approximately 30 days. According to the reviewers’ comments, the submitted papers are accepted or rejected. Submitted manuscripts must not have been previously published elsewhere and not currently be under review by another journal.


Processing and publication are free of charge. JPharmTech publishes three issues per year (April, August, and December) and accepts research articles and review articles on all aspects of pharmaceutical technology. Corresponding authors should submit their manuscripts through the online submission system of Dergipark. 

Cilt 1 - Sayı 1 - 1 Nis 2020
  1. Posaconazole loaded ocular inserts for antifungal activity
    Sayfalar 1 - 6
    Kadir AYKAÇ , Evrim YENİLMEZ , Müzeyyen DEMİREL , Ebru BAŞARAN
  2. Preparation, characterization and in-vitro evaluation of theophylline loaded microemulsion formulations
    Sayfalar 7 - 12
    Tilbe ÇEVİKELLİ , Deniz ONAN , Umay Merve GÜVEN , Esra DEMİRTÜRK
  3. Evaluation of the effect of anti-pollution & anti-aging eye cream on the collagen contraction
    Sayfalar 13 - 17
    Gülşah GEDİK , Seda ALACA
  4. An update on cyclodextrins as drug vehicles for antimicrobial applications
    Sayfalar 18 - 24
    Ece ÖZCAN BÜLBÜL , Kalliopi ELEFTHERIADOU , Neslihan ÜSTÜNDAĞ OKUR , Panoraia SİAFAKA
  5. Brain-targeted nanoparticles to overcome the blood-brain barrier
    Sayfalar 25 - 39
    Indrit SEKO , Adem ŞAHİN , Hayrettin TONBUL , Yılmaz ÇAPAN